Fig. 4From: 131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of MelanomaTime-dependent incorporation of 131I, PL-131I, FA-PL-131I, PLP-131I, and FA-PLP-131I on B16F10 cellsBack to article page